Overview
- 19 FDA inspections are on record.
- 13 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-10-28.
At a glance
Inspections
19
Form 483s
13
EIRs
2
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 20 Oct 2025 – 28 Oct 2025 | Human Drugs | 483 | On file |
| 28 Mar 2025 – 4 Apr 2025 | Human Drugs | 483 | On file |
| 20 Mar 2023 – 28 Mar 2023 | Human Drugs | 483 | On file |
| 10 Oct 2019 – 18 Oct 2019 | Human Drugs | 483 | On file |
| 13 May 2019 – 21 May 2019 | Human Drugs | 483 | On file |
| 25 Mar 2019 – 29 Mar 2019 | Human Drugs | 483 | On file |
| 11 Dec 2017 – 15 Dec 2017 | Human Drugs | 483 | On file |
| 3 Mar 2016 – 11 Mar 2016 | Human Drugs | 483 | On file |
| 23 Mar 2015 – 31 Mar 2015 | Human Drugs | 483 | On file |
| 21 Aug 2014 – 29 Aug 2014 | Human Drugs | 483 | On file |
| 1 Apr 2014 – 2 Apr 2014 | Foods & Cosmetics | Clean | |
| 8 Apr 2013 – 12 Apr 2013 | Human Drugs | Clean | |
Investigators
FDA investigators tied to this site in the record.
Reyes Candau-Chacon3 insp.
Anastasia G Lolas2 insp.
Ralph M Bernstein1 insp.
Lei Zhang1 insp.
Alexander R Sohr1 insp.
Thuy T Nguyen1 insp.
Melissa D Ray1 insp.
Hyung-Yul Lee1 insp.
Santos E Camara1 insp.
Vaishali J Patel1 insp.
Madushini N Dharmasena1 insp.
Zhong Li1 insp.
William Hallett1 insp.
Tiara N Brown-Crosen1 insp.
Maria J Lopez- Barragan1 insp.
Frances Namuswe1 insp.
V Ashutosh Rao1 insp.
Libia M Lugo1 insp.
Xiaokuang Lai1 insp.
Michael Shanks1 insp.
Zhihao Pete Qiu1 insp.
Brandon C Heitmeier1 insp.
Meredith P Soehl1 insp.
Herbert M Corbello1 insp.
Nadeem I Chaudhry1 insp.
Katherine Szestypalow1 insp.
Bo Chi1 insp.
Rebecca Rodriguez1 insp.
Kevin A Gonzalez1 insp.
Mary E Storch1 insp.
Full site report
Get the verbatim findings behind Lonza AG's 13 Form 483s
The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat